1.14
3.39%
-0.04
시간 외 거래:
1.18
0.04
+3.51%
Spero Therapeutics Inc (SPRO) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
87.40%
9.267
|
73.52 | 25.47 | 2.716 | 2.069 |
Operating Expenses
|
1.13%
23.25
|
22.99 | 27.41 | 15.61 | 16.30 |
Benefits Costs and Expenses |
72.01%
21.94
|
78.38 | - | 14.63 | 15.34 |
Costs And Expenses |
15.05%
21.94
|
19.07 | 27.41 | 14.63 | 15.34 |
Operating Income/Loss |
127.67%
-13.98
|
50.53 | -1.934 | -12.89 | -14.23 |
Nonoperating Income/Loss |
25.53%
1.313
|
1.046 | 0.94 | 0.976 | 0.961 |
Income/Loss From Continuing Operations Before Tax |
160.95%
-12.67
|
-4.855 | 25.47 | -11.91 | -13.27 |
Income/Loss From Continuing Operations After Tax |
124.75%
-12.67
|
51.19 | -3.205 | -11.91 | -13.27 |
Net Income/Loss
|
124.75%
-12.67
|
51.19 | -3.205 | -11.91 | -13.27 |
Preferred Stock Dividends And Other Adjustments |
306.67%
-0.031
|
0.015 | 0.005 | 0.014 | -0.034 |
Attributable To Noncontrolling Interest |
306.67%
0.031
|
-0.015 | -0.005 | -0.014 | 0.034 |
Basic Average Shares |
53,554%
53.52
|
0.0998 | 52.71 | 52.57 | 52.53 |
Diluted Average Shares |
13,791%
53.52
|
0.3853 | 52.71 | 52.57 | 52.53 |
Basic Earnings Per Share |
124.74%
-0.24
|
0.97 | -0.06 | -0.23 | -0.25 |
Diluted Earnings Per Share |
124.74%
-0.24
|
0.97 | -0.06 | -0.23 | -0.25 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
306.67%
-0.031
|
0.015 | 0.005 | 0.014 | -0.034 |
자본화:
|
볼륨(24시간):